GCMI and Rambam Medical Center Accelerator Evaluating 12 Israeli Startups for U.S. Commercialization.

In October 2018, GCMI and Rambam Medical Center announced the formation of a partnership to help Israeli medtech innovators commercialize their products in the U.S. healthcare market. Earlier this year, Georgia Bio and the Atlanta Chamber of Commerce recognized our work with a 2019 Phoenix Award recognizing leaders who have forged academic and industry relationships…

GCMI and BOTLab included in The New York Times: “Looking to Technology to Avoid Doctor’s Offices and Emergency Rooms.”

Revolutionizing the provision of patient care, improving outcomes and reducing overall cost through new medical technologies is serious business. It takes vision, technical prowess and efficient use of scarce resources in a rigorous regulatory landscape. Last month, The New York Times included the work GCMI and the American Cancer Society are doing with Dr. Darren…

Georgia Bio Names Atlanta’s Global Center for Medical Innovation and Israel’s Rambam Medical Center 2019 Phoenix Award Winner

February 14, 2019 (Atlanta, GA) – Georgia Bio, the state’s life science trade association, named GCMI and Rambam Medical Center 2019 Phoenix Award winners. Part of the Georgia Bio’s annual Golden Helix Award program, the Phoenix Award recognizes leaders who have forged academic and industry relationships that will drive translation, leading to new treatments and…

Atlanta and Israel launch new medtech accelerator

GCMI and the Rambam Health Care Campus, the largest medical center in northern Israel, announce the establishment of a medical technologies accelerator for Israeli-based companies in Atlanta. The agreement, which calls for joint funding, will be formally announced on October 10th at Metro Atlanta Chamber. The accelerator intends to provide promising Israeli medtech startups a…

First Digital Health Startup Enters Global Center for Medical Innovation (GCMI) Accelerator Program

September 10, 2018 (Atlanta, GA) – The Global Center for Medical Innovation (GCMI) announces it has selected Ares Health Systems as the first digital health startup for its “A1” accelerator program. “We have a well-developed population health solution, but need the commercialization pathway experience and health system relationships GCMI can provide to further prove our…

Realtime verification of chemotherapy effectiveness project awarded $100k grant for commercialization

Boston University’s BOTLab receives $100,000 in endeavor to turn science into commercialized product from American Cancer Society and Global Center for Medical Innovation. Fulfilling its recent commitment to identify, develop, and promote technology innovation within the ACS portfolio of funded research, the American Cancer Society (ACS) and Global Center for Medical Innovation (GCMI) teams have…

GCMI CEO Tiffany Wilson to present at U.S. Food & Drug Administration Public Meeting on Pediatric Medical Device Development

On August 14, 2018, GCMI CEO Tiffany Wilson will present before an open public meeting hosted by the U.S. FDA on Pediatric Medical Device Development in Silver Spring, MD. This meeting provides a discussion about strategies to enhance the medical device ecosystem to cultivate development and innovation of devices that serve the unique needs of…

Evaluating or Ready to Engage an Industry Leading Preclinical CRO? Connect with T3 Labs at TCT 2018, Booth 334!

The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on September 21-25, 2018 in San Diego, California. GCMI and T3 Labs will be attending as an exhibitor at TCT again this year. Our booth number is 334.  We’re excited to spend…